Acumen Diagnostics, a subsidiary of Q&M Dental group has won a tender from Singapore’s Ministry of Health to operate a Joint Testing and Vaccination Center (JTVC).
Acumen is 51% owned by Q&M and 49% owned by Aoxin Q & M Dental, a spin off from Q&M itself.
These centres provide testing and vaccination services in Singapore, and Q&M says that the operation of JTVCs by the private medical sector is part of the Singapore government’s policy and efforts to provide the public with efficient and convenient access to Covid-19 booster shot vaccinations.
Acumen’s 15-month contract, which is estimated at $3.6 million, commences on Oct 1 and ends on Dec 31, 2023, with actual operations starting from Nov 21.
Dr Ong Siew Hwa, CEO and chief scientist of Acumen Diagnostics, says that the best strategy to keep Singapore’s population safe and the Singapore economy open to protect livelihoods is for periodic Covid-19 booster shots, so as to counter the natural waning of immunity over time.
Shares of Q&M closed flat on Oct 11 at 33 cents.
